1.
Mok TSK, Leung TWT, Brown G, Moyses C, Chan ATC, Yeo W, et al. A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer. AO [Internet]. 2004 Apr. 1 [cited 2026 May 20];43(3):245-51. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26932